Orthopediatrics Corp Ownership
| KIDS Stock | USD 23.68 0.92 4.04% |
Shares in Circulation | First Issued 2015-03-31 | Previous Quarter 23.2 M | Current Value 23.2 M | Avarage Shares Outstanding 16.1 M | Quarterly Volatility 6.2 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Orthopediatrics | Build AI portfolio with Orthopediatrics Stock |
Orthopediatrics Stock Ownership Analysis
About 33.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.62. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Orthopediatrics Corp recorded a loss per share of 1.76. The entity had not issued any dividends in recent years. OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana. OrthoPediatrics Corp operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 133 people. To find out more about Orthopediatrics Corp contact Mark Throdahl at 574 268 6379 or learn more at https://www.orthopediatrics.com.Besides selling stocks to institutional investors, Orthopediatrics Corp also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Orthopediatrics Corp's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Orthopediatrics Corp's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Orthopediatrics Corp Quarterly Liabilities And Stockholders Equity |
|
Orthopediatrics Corp Insider Trades History
About 33.0% of Orthopediatrics Corp are currently held by insiders. Unlike Orthopediatrics Corp's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Orthopediatrics Corp's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Orthopediatrics Corp's insider trades
Orthopediatrics Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Orthopediatrics Corp is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Orthopediatrics Corp backward and forwards among themselves. Orthopediatrics Corp's institutional investor refers to the entity that pools money to purchase Orthopediatrics Corp's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Awm Investment Company Inc | 2025-03-31 | 545.3 K | New York State Common Retirement Fund | 2025-03-31 | 450.2 K | State Street Corp | 2025-03-31 | 445.4 K | Geode Capital Management, Llc | 2025-03-31 | 411.5 K | Marshall Wace Asset Management Ltd | 2025-03-31 | 355.8 K | Riverbridge Partners Llc | 2025-06-30 | 321 K | Goldman Sachs Group Inc | 2025-03-31 | 200.4 K | Kennedy Capital Management Inc | 2025-03-31 | 200 K | Northern Trust Corp | 2025-03-31 | 192.2 K | Brown Capital Management, Llc | 2025-03-31 | 1.7 M | Brown Advisory Holdings Inc | 2025-03-31 | 1.6 M |
Orthopediatrics Corp Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Orthopediatrics Corp insiders, such as employees or executives, is commonly permitted as long as it does not rely on Orthopediatrics Corp's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Orthopediatrics Corp insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Orthopediatrics Corp Outstanding Bonds
Orthopediatrics Corp issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Orthopediatrics Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Orthopediatrics bonds can be classified according to their maturity, which is the date when Orthopediatrics Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View |
Orthopediatrics Corp Corporate Filings
| 17th of July 2025 Other Reports | ViewVerify | |
F4 | 28th of May 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 27th of May 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
10Q | 8th of May 2025 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Orthopediatrics Stock Analysis
When running Orthopediatrics Corp's price analysis, check to measure Orthopediatrics Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orthopediatrics Corp is operating at the current time. Most of Orthopediatrics Corp's value examination focuses on studying past and present price action to predict the probability of Orthopediatrics Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orthopediatrics Corp's price. Additionally, you may evaluate how the addition of Orthopediatrics Corp to your portfolios can decrease your overall portfolio volatility.